High mRNA levels of EZH2, PRDM6, SETD5, and SETMAR were significantly associated with shorter survival in ccRCC patients, whereas only high NSD1 expression was correlated with longer survival in ccRCC (P < 0.05) (Fig. 5A; Fig. S1). This evidence concerns the gene EZH2 and nonpapillary renal cell carcinoma.